Skip to main content
Log in

Genetic polymorphisms of FSHR, CYP17, CYP1A1, CAPN10, INSR, SERPINE1 genes in adolescent girls with polycystic ovary syndrome

  • GENETICS
  • Published:
Journal of Assisted Reproduction and Genetics Aims and scope Submit manuscript

Abstract

Background

Polycystic ovary syndrome (PCOS), whose genetic basis is not completely well understood, is the most common endocrine disorder in women and it typically develops during adolescence. The aim of this study is to investigate the possible association between single nucleotide polymorphisms (SNPs) of FSHR, CYP17, CYP1A1, CAPN10, INSR, SERPINE1 genes and PCOS in adolescent girls.

Methods

DNA samples from forty-four adolescent girls with PCOS and 50 healthy controls were analyzed by PCR-RFLP and direct DNA sequencing to determine the genotypic frequency of 17 different polymorphic loci on the FSHR (A307T, N680S), CYP17 (−34 T/C), CYP1A1 (T6235C), CAPN10 (44, 43, 19, 63), INSR (exon 17 C/T), SERPINE1 (4G/5G) genes. Genotyping of exon 12 (six polymorphisms) and intron 12 (one polymorphism) of INSR gene by direct DNA sequencing was performed for the first time in this study.

Results

No significant differences were observed in the genotype and allele distributions of above mentioned polymorphisms between cases and control groups.

Conclusion

Our data does not support an association between SNPs of FSHR, CYP17, CYP1A1, CAPN10, INSR, SERPINE1 genes and susceptibility to PCOS or related traits in Turkish adolescent girls.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1

Similar content being viewed by others

References

  1. Franks S. Polycystic ovary syndrome in adolescents. Int J Obes. 2008;32(7):1035–41. doi:10.1038/ijo.2008.61.

    Article  CAS  Google Scholar 

  2. Ehrmann DA. Polycystic ovary syndrome. N Engl J Med. 2005;352(12):1223–36. doi:10.1056/NEJMra041536.

    Article  PubMed  CAS  Google Scholar 

  3. Luque-Ramírez M, San Millán JL, Escobar-Morreale HF. Genomic variants in polycystic ovary syndrome. Clin Chim Acta. 2006;366(1–2):14–26. doi:10.1016/j.cca.2005.10.017.

    Article  PubMed  CAS  Google Scholar 

  4. Valdés P, Cerda A, Barrenechea C, Kehr M, Soto C, Salazar LA. No association between common Gly972Arg variant of the insulin receptor substrate-1 and polycystic ovary syndrome in Southern Chilean women. Clin Chim Acta. 2008;390(1–2):63–6. doi:10.1016/j.cca.2007.12.018.

    Article  PubMed  CAS  Google Scholar 

  5. Simoni M, Tempfer CB, Destenaves B, Fauser BC. Functional genetic polymorphisms and female reproductive disorders: Part I: Polycystic ovary syndrome and ovarian response. Hum Reprod Update. 2008;14(5):459–84. doi:10.1093/humupd/dmn024.

    Article  PubMed  CAS  Google Scholar 

  6. Davis D, Liu X, Segaloff DL. Identification of the sites of N-linked glycosylation on the follicle-stimulating hormone (FSH) receptor and assessment of their role in FSH receptor function. Mol Endocrinol. 1995;9(2):159–70. doi:10.1210/me.9.2.159.

    Article  PubMed  CAS  Google Scholar 

  7. Hipkin RW, Liu X, Ascoli M. Truncation of the C-terminal tail of the follitropin receptor does not impair the agonist- or phorbol ester-induced receptor phosphorylation and uncoupling. J Biol Chem. 1995;270(44):26683–9. doi:10.1074/jbc.270.44.26683.

    Article  PubMed  CAS  Google Scholar 

  8. de Castro F, Ruiz R, Montoro L, et al. Role of follicle-stimulating hormone receptor Ser680Asn polymorphism in the efficacy of follicle-stimulating hormone. Fertil Steril. 2003;80(3):571–6. doi:10.1016/S0015-0282(03)00795-7.

    Article  PubMed  Google Scholar 

  9. Sudo S, Kudo M, Wada S, Sato O, Hsueh AJ, Fujimoto S. Genetic and functional analyses of polymorphisms in the human FSH receptor gene. Mol Hum Reprod. 2002;8(10):893–9. doi:10.1093/molehr/8.10.893.

    Article  PubMed  CAS  Google Scholar 

  10. Orio F Jr, Ferrarini E, Cascella T, et al. Genetic analysis of the follicle stimulating hormone receptor gene in women with polycystic ovary syndrome. J Endocrinol Invest. 2006;29(11):975–82.

    PubMed  CAS  Google Scholar 

  11. Tong Y, Liao WX, Roy AC, Ng SC. Absence of mutations in the coding regions of follicle-stimulating hormone receptor gene in Singapore Chinese women with premature ovarian failure and polycystic ovary syndrome. Horm Metab Res. 2001;33(4):221–6. doi:10.1055/s-2001-14941.

    Article  PubMed  CAS  Google Scholar 

  12. Lazar L, Kauli R, Bruchis C, Nordenberg J, Galatzer A, Pertzelan A. Early polycystic ovary-like syndrome in girls with central precocious puberty and exaggerated adrenal response. Eur J Endocrinol. 1995;133(4):403–6. doi:10.1530/eje.0.1330403.

    Article  PubMed  CAS  Google Scholar 

  13. Carey AH, Waterworth D, Patel K, et al. Polycystic ovaries and premature male pattern baldness are associated with one allele of the steroid metabolism gene CYP17. Hum Mol Genet. 1994;3(10):1873–6. doi:10.1093/hmg/3.10.1873.

    Article  PubMed  CAS  Google Scholar 

  14. Diamanti-Kandarakis E, Bartzis MI, Zapanti ED, et al. Polymorphism T-->C (-34 bp) of gene CYP17 promoter in Greek patients with polycystic ovary syndrome. Fertil Steril. 1999;71(3):431–5. doi:10.1016/S0015-0282(98)00512-3.

    Article  PubMed  CAS  Google Scholar 

  15. Marszalek B, Laciński M, Babych N, et al. Investigations on the genetic polymorphism in the region of CYP17 gene encoding 5'-UTR in patients with polycystic ovarian syndrome. Gynecol Endocrinol. 2001;15(2):123–8. doi:10.1080/713602803.

    Article  PubMed  CAS  Google Scholar 

  16. Park JM, Lee EJ, Ramakrishna S, Cha DH, Baek KH. Association study for single nucleotide polymorphisms in the CYP17A1 gene and polycystic ovary syndrome. Int J Mol Med. 2008;22(2):249–54.

    PubMed  CAS  Google Scholar 

  17. Echiburú B, Pérez-Bravo F, Maliqueo M, Sánchez F, Crisosto N, Sir-Petermann T. Polymorphism T-->C (-34 base pairs) of gene CYP17 promoter in women with polycystic ovary syndrome is associated with increased body weight and insulin resistance: a preliminary study. Metabolism. 2008;57(12):1765–71. doi:10.1016/j.metabol.2008.08.002.

    Article  PubMed  CAS  Google Scholar 

  18. Babu KA, Rao KL, Kanakavalli MK, Suryanarayana VV, Deenadayal M, Singh L. CYP1A1, GSTM1 and GSTT1 genetic polymorphism is associated with susceptibility to polycystic ovaries in South Indian women. Reprod Biomed Online. 2004;9(2):194–200.

    Article  PubMed  CAS  Google Scholar 

  19. Esinler I, Aktas D, Otegen U, Alikasifoglu M, Yaralı H, Tuncbilek E. CYP1A1 gene polymorphism and polycystic ovary syndrome. Reprod Biomed Online. 2008;16(3):356–60.

    PubMed  CAS  Google Scholar 

  20. Gaasenbeek M, Powell BL, Sovio U, et al. Large-scale analysis of the relationship between CYP11A promoter variation, polycystic ovarian syndrome, and serum testosterone. J Clin Endocrinol Metab. 2004;89(5):2408–13. doi:10.1210/jc.2003-031640.

    Article  PubMed  CAS  Google Scholar 

  21. Wang Y, Wu X, Cao Y, Yi L, Chen J. A microsatellite polymorphism (tttta)n in the promoter of the CYP11a gene in Chinese women with polycystic ovary syndrome. Fertil Steril. 2006;86(1):223–6. doi:10.1016/j.fertnstert.2005.12.037.

    Article  PubMed  CAS  Google Scholar 

  22. Horikawa Y, Oda N, Cox NJ, et al. Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus. Nat Genet. 2000;26(2):163–75. doi:10.1038/79876.

    Article  PubMed  CAS  Google Scholar 

  23. Baier LJ, Permana PA, Yang X, et al. A calpain-10 gene polymorphism is associated with reduced muscle mRNA levels and insulin resistance. J Clin Invest. 2000;106:R69–73. doi:10.1172/JCI10665.

    Article  PubMed  CAS  Google Scholar 

  24. Wiltgen D, Furtado L, Kohek MB, Spritzer PM. CAPN10 UCSNP-43, UCSNP-19 and UCSNP-63 polymorphisms and metabolic syndrome in polycystic ovary syndrome. Gynecol Endocrinol. 2007;23(3):173–8. doi:10.1080/09513590701233661.

    Article  PubMed  CAS  Google Scholar 

  25. Márquez JL, Pacheco A, Valdés P, Salazar LA. Association between CAPN10 UCSNP-43 gene polymorphism and polycystic ovary syndrome in Chilean women. Clin Chim Acta. 2008;398(1–2):5–9. doi:10.1016/j.cca.2008.07.028.

    Article  PubMed  CAS  Google Scholar 

  26. Ehrmann DA, Schwarz PE, Hara M, et al. Relationship of calpain-10 genotype to phenotypic features of polycystic ovary syndrome. J Clin Endocrinol Metab. 2002;87(4):1669–73. doi:10.1210/jc.87.4.1669.

    Article  PubMed  CAS  Google Scholar 

  27. Haddad L, Evans JC, Gharani N, et al. Variation within the type 2 diabetes susceptibility gene calpain-10 and polycystic ovary syndrome. J Clin Endocrinol Metab. 2002;87(6):2606–10. doi:10.1210/jc.87.6.2606.

    Article  PubMed  CAS  Google Scholar 

  28. Seino S, Seino M, Bell GI. Human insulin-receptor gene. Diabetes. 1990;39(2):129–33. doi:10.2337/diabetes.39.2.129.

    Article  PubMed  CAS  Google Scholar 

  29. Siegel S, Futterweit W, Davies TF, et al. A C/T single nucleotide polymorphism at the tyrosine kinase domain of the insulin receptor gene is associated with polycystic ovary syndrome. Fertil Steril. 2002;78(6):1240–3. doi:10.1016/S0015-0282(02)04241-3.

    Article  PubMed  Google Scholar 

  30. Chen ZJ, Shi YH, Zhao YR, et al. Correlation between single nucleotide polymorphism of insulin receptor gene with polycystic ovary syndrome. Zhonghua Fu Chan Ke Za Zhi. 2004;39(9):582–5.

    PubMed  Google Scholar 

  31. Jin L, Huang HF, Jin F, Qian YL. Polymorphism in insulin receptor gene exon 17 in women with polycystic ovary syndrome. Zhonghua Fu Chan Ke Za Zhi. 2005;40(5):323–6.

    PubMed  CAS  Google Scholar 

  32. Lee EJ, Oh B, Lee JY, Kimm K, Lee SH, Baek KH. A novel single nucleotide polymorphism of INSR gene for polycystic ovary syndrome. Fertil Steril. 2008;89(5):1213–20. doi:10.1016/j.fertnstert.2007.05.026.

    Article  PubMed  CAS  Google Scholar 

  33. Diamanti-Kandarakis E, Palioniko G, Alexandraki K, Bergiele A, Koutsouba T, Bartzis M. The prevalence of 4G5G polymorphism of plasminogen activator inhibitor-1 (PAI-1) gene in polycystic ovarian syndrome and its association with plasma PAI-1 levels. Eur J Endocrinol. 2004;150(6):793–8. doi:10.1530/eje.0.1500793.

    Article  PubMed  CAS  Google Scholar 

  34. San Millán JL, Cortón M, Villuendas G, Sancho J, Peral B, Escobar-Morreale HF. Association of the polycystic ovary syndrome with genomic variants related to insulin resistance, type 2 diabetes mellitus, and obesity. J Clin Endocrinol Metab. 2004;89(6):2640–6. doi:10.1210/jc.2003-031252.

    Article  PubMed  CAS  Google Scholar 

  35. Walch K, Grimm C, Huber JC, Nagele F, Kolbus A, Hefler LA. A polymorphism of the plasminogen activator inhibitor-1 gene promoter and the polycystic ovary syndrome. Eur J Obstet Gynecol Reprod Biol. 2005;123(1):77–81. doi:10.1016/j.ejogrb.2005.07.002.

    Article  PubMed  CAS  Google Scholar 

  36. Karadeniz M, Erdogan M, Berdeli A, Saygili F, Yilmaz C. 4G/5G polymorphism of PAI-1 gene and Alu-repeat I/D polymorphism of TPA gene in Turkish patients with polycystic ovary syndrome. J Assist Reprod Genet. 2007;24(9):412–8. doi:10.1007/s10815-007-9160-7.

    Article  PubMed  Google Scholar 

  37. Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril. 2004;81(1):19–25. doi:10.1016/j.fertnstert.2003.10.004.

    Article  Google Scholar 

  38. Sundblad V, Chiauzzi VA, Escobar ME, Dain L, Charreau EH. Screening of FSH receptor gene in Argentine women with premature ovarian failure (POF). Mol Cell Endocrinol. 2004;222(1–2):53–9. doi:10.1016/j.mce.2004.05.002.

    Article  PubMed  CAS  Google Scholar 

  39. Yang CQ, Chan KY, Ngan HY, et al. Single nucleotide polymorphisms of follicle-stimulating hormone receptor are associated with ovarian cancer susceptibility. Carcinogenesis. 2006;27(7):1502–6. doi:10.1093/carcin/bgl014.

    Article  PubMed  CAS  Google Scholar 

  40. Onen IH, Ekmekci A, Eroglu M, Polat F, Biri H. The association of 5alpha-reductase II (SRD5A2) and 17 hydroxylase (CYP17) gene polymorphisms with prostate cancer patients in the Turkish population. DNA Cell Biol. 2007;26(2):100–7. doi:10.1089/dna.2006.0534.

    Article  PubMed  CAS  Google Scholar 

  41. Hirata H, Hinoda Y, Okayama N, et al. CYP1A1, SULT1A1, and SULT1E1 polymorphisms are risk factors for endometrial cancer susceptibility. Cancer. 2008;112(9):1964–73. doi:10.1002/cncr.23392.

    Article  PubMed  CAS  Google Scholar 

  42. Daimon M, Oizumi T, Saitoh T, et al. Calpain 10 gene polymorphisms are related, not to type 2 diabetes, but to increased serum cholesterol in Japanese. Diabetes Res Clin Pract. 2002;56(2):147–52. doi:10.1016/S0168-8227(01)00372-2.

    Article  PubMed  CAS  Google Scholar 

  43. Shima Y, Nakanishi K, Odawara M, Kobayashi T, Ohta H. Association of the SNP-19 genotype 22 in the calpain-10 gene with elevated body mass index and hemoglobin A1c levels in Japanese. Clin Chim Acta. 2003;336(1–2):89–96. doi:10.1016/S0009-8981(03)00320-6.

    Article  PubMed  CAS  Google Scholar 

  44. Orho-Melander M, Klannemark M, Svensson MK, Ridderstråle M, Lindgren CM, Groop L. Variants in the calpain-10 gene predispose to insulin resistance and elevated free fatty acid levels. Diabetes. 2002;51(8):2658–64. doi:10.2337/diabetes.51.8.2658.

    Article  PubMed  CAS  Google Scholar 

  45. Brown NJ, Murphey LJ, Srikuma N, Koschachuhanan N, Williams GH, Vaughan DE. Interactive effect of PAI-1 4G/5G genotype and salt intake on PAI-1 antigen. Arterioscler Thromb Vasc Biol. 2001;21(6):1071–7.

    PubMed  CAS  Google Scholar 

  46. Seino S, Seino M, Bell GI. Human insulin-receptor gene. Partial sequence and amplification of exons by polymerase chain reaction. Diabetes. 1990;39(1):123–8. doi:10.2337/diabetes.39.1.123.

    Article  PubMed  CAS  Google Scholar 

  47. Amato P, Simpson JL. The genetics of polycystic ovary syndrome. Best Pract Res Clin Obstet Gynaecol. 2004;18(5):707–18. doi:10.1016/j.bpobgyn.2004.05.002.

    Article  PubMed  Google Scholar 

  48. Conway GS, Conway E, Walker C, Hoppner W, Gromoll J, Simoni M. Mutation screening and isoform prevalence of the follicle stimulating hormone receptor gene in women with premature ovarian failure, resistant ovary syndrome and polycystic ovary syndrome. Clin Endocrinol (Oxf). 1999;51(1):97–9. doi:10.1046/j.1365-2265.1999.00745.x.

    Article  CAS  Google Scholar 

  49. Liović M, Prezelj J, Kocijancic A, Majdic G, Komel R. CYP17 gene analysis in hyperandrogenised women with and without exaggerated 17-hydroxyprogesterone response to ovarian stimulation. J Endocrinol Invest. 1997;20(4):189–93.

    PubMed  Google Scholar 

  50. Gonzalez A, Abril E, Roca A, et al. Comment: CAPN10 alleles are associated with polycystic ovary syndrome. J Clin Endocrinol Metab. 2002;87(8):3971–6. doi:10.1210/jc.87.8.3971.

    Article  PubMed  CAS  Google Scholar 

  51. Vollmert C, Hahn S, Lamina C, et al. Calpain-10 variants and haplotypes are associated with polycystic ovary syndrome in Caucasians. Am J Physiol Endocrinol Metab. 2007;292(3):E836–44. doi:10.1152/ajpendo.00584.2005.

    Article  PubMed  CAS  Google Scholar 

  52. Lee EJ, Yoo KJ, Kim SJ, Lee SH, Cha KY, Baek KH. Single nucleotide polymorphism in exon 17 of the insulin receptor gene is not associated with polycystic ovary syndrome in a Korean population. Fertil Steril. 2006;86(2):380–4. doi:10.1016/j.fertnstert.2005.12.073.

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgements

This study has been supported by the Gazi University Research Fund, with the project code number 01/2006-05.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Ece Konac.

Appendix

Appendix

Supporting document

Gene structure and linkage disequilibrium plot for CAPN10. The locations of the genotyped SNPs (UCSNP44, 43, 19 and 63) relative to the introns are indicated. The linkage disequilibrium plot at the bottom displays D' values (percent) for each pair of SNPs in the box at the intersection of the diagonals from each SNP.

figure a

Pair wise linkage disequilibrium between the SNPs were carried out using Haploview version 4.0 (http://www.broad.mit.edu/mpg/haploview). However, CAPN10 UCSNP44 was not in linkage disequilibrium with UCSNP 43 and UCSNP63. In addition, CAPN10 UCSNP43 was not in linkage disequilibrium with UCSNP 44 and UCSNP63. Therefore, neither conducting a haplotype analyses nor calculating potential associations among these four different polymorphisms of CAPN10 gene is necessary.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Unsal, T., Konac, E., Yesilkaya, E. et al. Genetic polymorphisms of FSHR, CYP17, CYP1A1, CAPN10, INSR, SERPINE1 genes in adolescent girls with polycystic ovary syndrome. J Assist Reprod Genet 26, 205–216 (2009). https://doi.org/10.1007/s10815-009-9308-8

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10815-009-9308-8

Keywords

Navigation